COGT Earnings Date: Nov 6, 2026 (Estimated) — Cogent Biosciences, Inc.
NASDAQ
Updated
When is COGT's next earnings date?
Cogent Biosciences, Inc. (COGT) is expected to report Q3 2026 earnings on Friday, November 6, 2026 at 9:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.56 on revenue of $750,000.
How did COGT do in its last earnings report?
In its most recent report on Aug 10, 2026 (Q2 2026), Cogent Biosciences, Inc. posted EPS of -$0.52 versus the -$0.56 estimate, a beat of 7.1%. Revenue was $0 against a $1,000 estimate. The stock's 1-day post-earnings move was -2.0%.
How much does COGT stock move after earnings?
COGT beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 3.0% (up or down) in the day after earnings.
About Cogent Biosciences, Inc.
Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib. Previously known as Unum Therapeutics Inc., the company adopted its current name, Cogent Biosciences, Inc., in October 2020. Established in 2014, Cogent Biosciences is headquartered in Cambridge, Massachusetts.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | Q2 2026 | -0.56 | -0.52 | +7.14% | $0 | ✅ Beat | -2.03% | -10.52% | -16.77% |
| 2026-05-05 | Q1 2026 | -0.54 | -0.53 | +1.85% | $0 | ✅ Beat | +0.68% | -7.16% | -12.17% |
| 2026-02-17 | Q4 2025 | -0.51 | -0.61 | -19.61% | $0 | ❌ Miss | +2.98% | +1.45% | -3.04% |
| 2025-11-03 | Q3 2025 | -0.52 | -0.50 | +3.85% | $0 | ✅ Beat | -4.91% | -9.08% | +139.14% |
| 2025-08-05 | Q2 2025 | -0.57 | -0.53 | +7.02% | $0 | ✅ Beat | -5.73% | -9.29% | +8.55% |
| 2025-02-25 | Q4 2024 | -0.58 | -0.09 | +84.48% | $0 | ✅ Beat | -6.30% | -6.17% | -7.51% |
| 2024-11-12 | Q3 2024 | -0.57 | -0.64 | -12.28% | $0 | ❌ Miss | -0.19% | -13.56% | -10.87% |
| 2024-08-06 | Q2 2024 | -0.56 | -0.59 | -5.36% | $0 | ❌ Miss | +1.31% | -7.00% | +25.60% |
Showing last 8 quarters.